The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The microtubule-destabilizing agent AUS_001 as a candidate for glioblastoma therapy.
 
Marina Koutsioumpa
Employment - Australis Pharma
Leadership - Australis Pharma
Stock and Other Ownership Interests - Kyn therapeutics
Patents, Royalties, Other Intellectual Property - University of California, Los Angeles, Los Angeles
Travel, Accommodations, Expenses - Australis Pharma
 
Aaron L. Carlson
Employment - Kiyatec
 
Tessa DesRochers
Employment - KIYATEC
Leadership - KIYATEC
Patents, Royalties, Other Intellectual Property - Patent #: US 20150247112 A1
Travel, Accommodations, Expenses - KIYATEC
 
Peter Y.W. Chan
No Relationships to Disclose
 
April L. Risinger
Employment - Molecular devices (I)
Research Funding - Eisai - Sponsored Research Agreement (Inst)
Patents, Royalties, Other Intellectual Property - UT System
 
Robert Adams
No Relationships to Disclose
 
Cedric Bardy
Research Funding - Australis Pharmaceuticals - Sponsored Research Agreement (Inst)
 
Daniel Thomas
No Relationships to Disclose
 
Herman Lelie
Leadership - Australis Pharma
Stock and Other Ownership Interests - Pfizer, Astra Zeneca, Moderna
Consulting or Advisory Role - Australis Pharma
Patents, Royalties, Other Intellectual Property - Bruin Biometrics, LLC.